Avoiding collateral damage in Alzheimer's disease treatment

Science

Volumn 314, Issue 5799, 2006, Pages 602-603

  Glabe, Charles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA SECRETASE; NEU DIFFERENTIATION FACTOR; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BACE1 PROTEIN, MOUSE; PROTEINASE; PROTEINASE INHIBITOR; SECRETASE;

DISEASE INCIDENCE; DISEASE TREATMENT;

ALZHEIMER DISEASE; CONFORMATIONAL TRANSITION; ENZYME INHIBITION; HUMAN; MYELINATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING; REVIEW; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; MOUSE; MYELIN SHEATH; NERVE CELL; NERVE FIBER; NOTE; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN FOLDING; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; AXONS; ENDOPEPTIDASES; HUMANS; MICE; MICE, TRANSGENIC; MYELIN SHEATH; NEUREGULIN-1; NEURONS; PROTEASE INHIBITORS; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 33750487846     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1135043     Document Type: Review

References (12)

1. R. Vassar et al., Science 286, 735 (1999).
2. Y. Luo et al., Nat. Neurosci. 4, 231 (2001).
3. H. Cai et al., Nat. Neurosci. 4, 233 (2001).
4. M. Willem et al., Science 314, 664 (2006); published online 21 September 2006 (10.1126/science.1132341).
5. C. Haass, EMBO J. 23, 483 (2004).
6. B. De Strooper et al., Nature 391, 387 (1998).
7. B. De Strooper et al., Nature 398, 518 (1999).
8. G. V. Michailov et al., Science 304, 700 (2004); published online 25 March 2004 (10.1126/science. 1095862).
9. C. Taveggia et al., Neuron 47, 681 (2005).
10. K. Horiuchi, H. M. Zhou, K. Kelly, K. Manova, C. P. Slobel, Dev. Biol. 283, 459 (2005).
11. J. Bao et al., J Cell Biol. 161, 1133 (2003).
12. The author is a paid consultant for Kinexis Inc., whose therapeutic interests include Alzheimer's disease.